Nutritional management of inflammatory bowel disease;Manejo nutricional de la enfermedad inflamatoria intestinal

Endocrinologia y Nutricion

Volumn 54, Issue 3, 2007, Pages 151-168

  Arrizabalaga, Juan José ^a  

^a HOSPITAL TXAGORRITXU   (Spain)

Author keywords

Crohn's disease; Dietetic and nutritional therapies; Inflammatory bowel disease; Malnutrition; Nutritional management; Ulcerative colitis

Indexed keywords

ANTIOXIDANT; OMEGA 3 FATTY ACID; PREBIOTIC AGENT; STEROID; TRANSFORMING GROWTH FACTOR BETA;

CROHN DISEASE; DIET THERAPY; DRUG CONTRAINDICATION; ENTERIC FEEDING; GROWTH DISORDER; HUMAN; NUTRITIONAL STATUS; PROTEIN CALORIE MALNUTRITION; REVIEW; TREATMENT FAILURE; ULCERATIVE COLITIS; VITAMIN DEFICIENCY;

EID: 34047220303     PISSN: 15750922     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1575-0922(07)71424-9     Document Type: Review

References (61)

1. Riera J. Definiciones conceptuales de la enfermedad inflamatoria intestinal. Concepto de cronicidad. En: Gassull MA, Gomollón F, Obrador A, Hinojosa J, editores. Enfermedad inflamatoria intestinal, II edición. Madrid: Ergon, 2002;3-5.
2. Podolsky DK. Inflammatory bowel disease. N Engl J Med. 2002;347:417-29.
3. Hanauer SB. Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities. Inflam Bowel Dis. 2006;12 Suppl 1:S3-S9.
4. Saro C, Ruiz V. Epidemiología y factores de riesgo de la enfermedad inflamatoria intestinal. En: Gassull MA, Gomollón F, Obrador A, Hinojosa J, editores. Enfermedad inflamatoria intestinal, II edición. Madrid: Ergón, 2002;7-19.
5. Shanahan F. Crohn's disease. Lancet. 2002;359:62-9.
6. Ekbom A. Epidemiology of inflammatory bowel disease. En: Bristian BR, Walker-Smith JA, editores. Inflammatory bowel diseases. Basel: Karger; 1999. p. 7-21.
7. Dionne S, Ruemmele FM, Seidman EG. Immunopathogenesis of inflammatory bowel disease: role of cytokines and immune cell-enterocyte interactions. En: Bristian BR, Walker-Smith JA, editores. Inflammatory bowel diseases. Basel: Karger; 1999. p. 41-61.
8. Rosenberg IH, Mason JB. Inflammatory bowel disease. En: Shils ME, Young VR, editors. Modern nutrition in health and disease. Filadelfia: Lea & Febiger; 1994. p. 1043-8.
9. Dieleman LA, Heizer WD. Nutritional issues in inflammatory bowel disease. Gastroenterol Clin North Am. 1998;27:435-51.
10. Griffiths AM. Inflammatory bowel disease. En: Shils ME, Olson JA, Shike M, Ross AC, editors. Modern nutrition in helth and disease. 9th ed. Baltimore: Williams & Wilkins; 1999. p. 1141-9.
11. Jeejeeboy KN. Nutrition versus drug therapy. En: Bristian BR, Walker-Smith JA, editors. Inflammatory bowel diseases. Basel: Karger; 1999. p. 139-54.
12. Fernández Bañares F, Gassull MA. Revisión y consenso en terapia nutricional: nutrición en enfermedad inflamatoria intestinal. Nutr Hosp. 1999;14 Supl 2:71S-80S.
13. a ed. Madrid: Ergón; 2002. p. 351-8.
14. Cabré E, Gassull MA. Nutrición en la enfermedad inflamatoria intestinal. En: Gil A, Álvarez J, García de Lorenzo A, Montejo JC, Planas M, editores. Tratado de Nutrición, tomo IV. Madrid: Acción Médica; 2005. p. 880-906.
15. Bistrian BR. Role of the sistemic inflammatory response in the development of protein-energy malnutrition in inflammatory bowel disease. En: Bistrian BR, Walker-Smith JA, editores. Inflammatory bowel diseases. Basel: Karger; 1999. p. 1-6.
16. Geerling BJ, Badart-Smook A, Stockbrügger RW, Brummer RJM. Comprehensive nutritional status in patients with long-standing Crohn disease currently in remission. Am J Clin Nutr. 1998;67:919-26.
17. Kastin DA, Buchman AL. Malnutrition and gastrointestinal disease. Curr Opin Nutr Metab Care. 2002;5:699-706.
18. 12 "Cobalamin". En: Shils ME, Olson JA, Shike M, Ross AC, editores. Modern nutrition in helth and disease. 9th ed. Baltimore: Williams & Wilkins; 1999. p. 447-58.
19. Oldenburg B, Fijnheer R, Van der Griend R, Van Berge-Henegouwen GP, Koningsberger JC. Homocysteine in inflammatory bowel disease: a risk factor for thromboembolic complications? Am J Gastroenterol. 2000;95:2825-30.
20. Griffiths AM. Enfermedad inflamatoria intestinal pediátrica: peculiaridades y objetivos específicos. En: Gassull MA, Gomollón F, Obrador A, Hinojosa J, editores. Enfermedad inflamatoria intestinal, II edición. Madrid: Ergón; 2002;359-71.
21. Escher JC, Taminiau JAJM, Nieuwenhuis EES, Buller HA, Grand RJ. Treatment of inflammatory bowel disease in childhood: best available evidence. Inflamm Bowel Dis. 2003;9:34-58.
22. Kleinman RE, Baldassano RN, Caplan A, Griffiths AM, Heyman MB, Issenman RM, et al. Nutrition support for pediatric patients with inflammatory bowel disease: a clinical report of North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr. 2004;39:15-27.
23. Newby EA, Sawczenko A, Thomas AG, Wilson D. Intervenciones frente al retraso del crecimiento en niños con enfermedad de Crohn (Revisión Cochrane traducida). En: La Biblioteca Cochrane Plus, 2005 Número 4. Oxford: Update Software Ltd. Disponible en: http://www.update-software.com (Traducida de The Cochrane Library, 2005 Issue 4. Chichester, UK: John Wiley & Sons, Ltd.).
24. American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. J Parenter Enteral Nutr. 2002;26 Suppl 1:73SA-4SA;115SA-7SA.
25. Virgili N, Leyes P, Pita AM. Nutrición en enfermedades digestivas. En: Tratado de nutrición artificial. Celaya S, editor. Madrid: Aula Médica; 1998. p. 385-99.
26. Carter MJ, Lobo AJ, Travis SPL. Guidelines for the management of inflammatory bowel disease in adults. Gut. 2004;53 Suppl V:v1-v16.
27. Cuerda MC, Bretón I, Camblor M, García Peris P. Soporte nutricional basado en la evidencia en la enfermedad inflamatoria intestinal. En: Bellido D, Ballesteros MD, Álvarez J, Del Olmo D, editores. Nutrición basada en la evidencia. Endocrinol Nutr. 2005;52 Supl 2:70-7.
28. Nelson JK, Moxness KE, Jensen MD, Gastineau CF. Dietética y Nutrición: Manual de la Clínica Mayo. Madrid: Mosby-Doyma; 1996. p. 261-4.
29. Suárez FL, Adshead J, Furne JK, Levitt MD. Lactose maldigestion is not an impediment to the intake of 1,500 mg calcium daily as dairy products. Am J Clin Nutr. 1998;68:1118-22.
30. Kolars JC, Levitt MD, Mostafa A, Savaiano DA. Yogurt: an autodigesting source of lactose. N Engl J Med. 1984;310:1-3.
31. Rosinach M, Maurer-Pons A, Domènech E, Deselaers A, García-Planella E, Bernal I, et al. ¿Es necesario suprimir los lácteos de la dieta en los brotes de actividad de la enfermedad inflamatoria intestinal? [resumen] Gastroenterol Hepatol. 2002;25:198-9.
32. Nelson JK, Moxness KE, Jensen MD, Gastineau CF. Dietética y Nutrición: Manual de la Clínica Mayo. Madrid: Mosby-Doyma; 1996. p. 247-58.
33. Riordan AM, Hunter JO, Cowan RE, Crampton JR, Davidson AR, Dickinson RJ, et al. Treatment of active Crohn's disease by exclusion diet: East Anglian multicentre controlled trial. Lancet. 1993;342:1131-4.
34. Pearson M, Teahon K, Jonathan Levi A, Bjarnason I. Food intolerance and Crohn's disease. Gut. 1993;34:783-7.
35. Jowett SL, Seal CJ, Phillips E, Gregory W, Barton JR, Welfare MR. Dietary beliefs of people with ulcerative colitis and their effect on relapse and nutrient intake. Cin Nutr. 2004;23:1 61-70.
36. Jowett SL, Seal CJ, Pearce MS, Phillips E, Gregory W, Barton JR, et al. Influence of dietary factors on the clinical course of ulcerative colitis: a prospective cohort study. Gut. 2004;53:1479-84.
37. Kupferman ME, Rombeau JL. Parenteral nutrition in inflammatory bowel disease. En: Rombeau JL, Rolandelli RH, editores. Parenteral nutrition. Filadelfia: WB Saunders; 2001. p. 208-29.
38. a ed. Madrid: Ergon; 2002. p. 233-40.
39. Zachos M, Tondeur M, Griffiths AM. Nutrición enteral para la inducción de remisión en la enfermedad de Crohn (Revisión Cochrane traducida). En: La Biblioteca Cochrane Plus, 2005 Número 4. Oxford: Update Software Ltd. Disponible en: http://www.update-software.com (Traducida de The Cochrane Library, 2005 Issue 4. Chichester, UK: John Wiley & Sons, Ltd.).
40. Griffiths AM, Ohlsson A, Sherman PM, Sutherland RL. Meta-analysis of enteral nutrition as a primary tratment of active Crohn's disease. Gastroenterology. 1995;108:1056-67.
41. Fernández-Bañares F, Cabré E, Esteve-Comas M, Gassull MA. How effective is enteral nutrition in inducing clinical remission in active Crohn's disease?. A meta-analysis of the randomized clinicals trials. J Parenter Enteral Nutr. 1995;19:356-64.
42. Messori A, Trallori G, D'Albasio G, Milla M, Vannozzi G, Pacini F. Defined-formula diets versus steroids in the treatment of active Crohn's disease. A meta-analysis. Scand J Gastroenterol. 1996;31:267-72.
43. Seidman E. Nutritional therapy for Crohn's disease: lessons from the Ste-Justine Hospital experience. Inflam Bowel Dis. 1997;3:S43-S5.
44. Ruemmele FM, Roy CC, Levy E, Seidman EG. Nutrition as primary therapy in pediatric Crohn's disease: Fact or fantasy? J Pediatr. 2000;136:285-91.
45. Heuschkel R, Menache CC, Megerian JT, Baird AE. Enteral nutrition and corticosteroids in the treatment of acute Crohn's disease in children. J Pediatr Gastroenterol Nutr. 2000;31:8-15.
46. Griffiths AM. Enteral nutrition in the management of Crohn's disease. J Parenter Enteral Nutr. 2005;29(Suppl):S108-S17.
47. Dray X, Marteau P. The use of enteral nutrition in te management of Crohn's disease in adults. J Parenter Enteral Nutr. 2005;29(Suppl):S166-S72.
48. Proceedings from de wokshop "Use of nutrition in the management and treatment of inflammatory bowel disease" [Concluding Remarks]. J Parenter Enteral Nutr. 2005;29(Suppl):184S-8S.
49. Gassull MA. New insights in nutritional therapy in inflammatory bowel disease. Clin Nutr. 2001;20(Suppl 1):113-21.
50. Gassull MA, Cabré E. Nutrition in inflammatory bowel disease. Curr Opin Clin Nutr Metab Care. 2001;4:561-9.
51. Gassull MA, Mañé J, Pedrosa E, Cabré E. Macronutrients and bioactive molecules: is there a specific role in the management of inflammatory bowel disease? J Parenter Enteral Nutr. 2005;29(Suppl):S179-S83.
52. Mitsuyama K, Saiki T, Kanauchi O, Iwanaga T, Tomiyasu N, Nishiyama T, et al. Treatment of ulcerative colitis with germinated barley foodstuff feeding: a pilot study. Aliment Pharmacol Ther. 1998;12:1225-30.
53. Fedorak RN, Masden KL. Probiotics and the management of inflammatory bowel disease. Inflamm Bowel Dis. 2004;10:286-99.
54. Middleton SJ, Rucker JT, Kirby GA, Riordan AM, Hunter JO. Long-chain triglycerides reduce the efficacy of enteral feeds in patients with active Crohn's disease. Clin Nutr. 1995;14:229-36.
55. Sakurai T, Matsui T, Yao T, Takagi Y, Hirai F, Aoyagi K, et al. Short-term efficacy of enteral nutrition in the treatment of active Crohn's disease: a randomized, controlled trial comparing nutrient formulas. J Parenter Enteral Nutr. 2002;26:98-103.
56. Gassull MA, Fernández-Bañares F, Cabré E, Papo M, Giaffer MH, Sánchez-Lombraña JL. Fat composition may be a clue to explain the primary therapeutic effect of enteral nutrition in Crohn's disease: results of a double blind randomised multicentre European trial. Gut. 2002;51:164-8.
57. Belluzzi A, Boschi S, Brignola C, Munarini A, Cariani G, Miglio F. Polyunsaturated fatty acids and inflammatory bowel disease. Am J Clin Nutr. 2000;71(Suppl):339S-42S.
58. Akobeng AK, Miller V, Stanton J, Elbadri AM, Thomas AG. Double-blind randomized controlled trial of glutamine-enriched polymeric diet in me treatment of active Crohn's disease. J Pediatr Gastroenterol Nutr. 2000;30:78-84.
59. Fell JME. Control of sistemic and local inflammation with transforming growth factor contaning formulas. J Parenter Enteral Nutr. 2005;29(Suppl):S126- S33.
60. Lomer MCE, Thompson RPH, Powell JJ. Fine and ultrafine particles of the diet: influence on the mucosal immune response and association with Crohn's disease. Proc Nutr Soc. 2002;61:123-30.
61. Lomer MCE, Harvey RSJ, Evans SM, Thompson RPH, Powell JJ. Efficacy and tolerability of a low microparticle diet in a double blind, randomized, pilot study in Crohn's disease. Eur J Gastroenterol Hepatol. 2001;13:101-6.